IFP Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-165
| Closed | -$3.55K | – | 5261 |
|
|
2026
Q2 | $3.55K | Sell |
165
-475
| -74% | -$10.2K | ﹤0.01% | 3977 |
|
|
2026
Q1 | $13.7K | Buy |
640
+111
| +21% | +$1.56K | ﹤0.01% | 2994 |
|
|
2025
Q4 | $4.93K | Buy |
529
+67
| +15% | +$560 | ﹤0.01% | 3419 |
|
|
2025
Q3 | $3.26K | Buy |
462
+404
| +697% | +$2.78K | ﹤0.01% | 3475 |
|
|
2025
Q2 | $377 | Buy |
58
+34
| +142% | +$234 | ﹤0.01% | 4501 |
|
|
2025
Q1 | $190 | Sell |
24
-3
| -11% | -$32 | ﹤0.01% | 3681 |
|
|
2024
Q4 | $342 | Buy |
27
+3
| +13% | +$42 | ﹤0.01% | 3522 |
|
|
2024
Q3 | $334 | Hold |
24
| – | – | ﹤0.01% | 3175 |
|
|
2024
Q2 | $331 | Hold |
24
| – | – | ﹤0.01% | 3115 |
|
|
2024
Q1 | $396 | Hold |
24
| – | – | ﹤0.01% | 2998 |
|
|
2023
Q4 | $350 | Hold |
24
| – | – | ﹤0.01% | 2904 |
|
|
2023
Q3 | $294 | Buy |
+24
| New | +$313 | ﹤0.01% | 3158 |
|
IFP Advisors's DAWN Position: Q3 2026 in Review
IFP Advisors sold out of Day One Biopharmaceuticals (DAWN) in Q3 2026, closing a stake of 165 shares — an estimated $3.55K sold.
IFP Advisors first reported a position in DAWN in Q3 2023 and held it in 12 quarters. The position peaked at $13.7K in Q1 2026. 0 funds tracked by Wall St. Rank hold DAWN as of Q3 2026.
- IFP Advisors reported no remaining Day One Biopharmaceuticals position as of Q3 2026 after selling out during the quarter.
- IFP Advisors sold 165 Day One Biopharmaceuticals shares in Q3 2026, an estimated $3.55K.
- IFP Advisors first reported a position in Day One Biopharmaceuticals in Q3 2023 and held it in 12 quarters.
- IFP Advisors's Day One Biopharmaceuticals position peaked at $13.7K in Q1 2026.
- 0 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.